Xu BH - Search Results

1

Phase II multi-center clinical study on using S-1 to treat advanced breast cancer after resistance to anthracycline and taxane drugs in Chinese patients.

Yuan P, Di LJ, Liu W, Wan DG, Dai H, Tong ZS, Du F, Xu BH. Yuan P, et al. Among authors: xu bh. Int J Clin Exp Med. 2015 Feb 15;8(2):3072-9. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 25932284 Free PMC article.

2

[Serum her-2/neu level and related factors in patients with breast cancer].

Yuan P, Xu BH, Zhang C, Qi J. Yuan P, et al. Among authors: xu bh. Zhonghua Zhong Liu Za Zhi. 2003 Nov;25(6):573-4. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 14690565 Chinese.

3

Correlation between serum HER-2 oncoprotein and patients with breast cancer.

Yuan P, Xu BH, Chu DT. Yuan P, et al. Among authors: xu bh. Chin Med Sci J. 2004 Sep;19(3):212-5. Chin Med Sci J. 2004. PMID: 15506651

4

[Polymorphisms in nucleotide excision repair genes XPC and XPD and clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer].

Yuan P, Miao XP, Zhang XM, Wang ZH, Tan W, Sun Y, Xu BH, Lin DX. Yuan P, et al. Among authors: xu bh. Zhonghua Yi Xue Za Zhi. 2005 Apr 13;85(14):972-5. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16061005 Chinese.

5

[Correlation of genetic polymorphisms in nucleotide excision repair system to sensitivity of advanced non-small cell lung cancer patients to platinum-based chemotherapy].

Yuan P, Miao XP, Zhang XM, Wang ZH, Tan W, Zhang XR, Sun Y, Xu BH, Lin DX. Yuan P, et al. Among authors: xu bh. Ai Zheng. 2005 Dec;24(12):1510-3. Ai Zheng. 2005. PMID: 16351803 Chinese.

6

[Association of the responsiveness of advanced non-small cell lung cancer to platinum-based chemotherapy with p53 and p73 polymorphisms].

Yuan P, Miao XP, Zhang XM, Wang ZH, Tan W, Zhang XR, Sun Y, Xu BH, Lin DX. Yuan P, et al. Among authors: xu bh. Zhonghua Zhong Liu Za Zhi. 2006 Feb;28(2):107-10. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16750013 Chinese.

7

[XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer].

Yuan P, Miao XP, Zhang XM, Wang ZH, Tan W, Sun Y, Zhang XR, Xu BH, Lin DX. Yuan P, et al. Among authors: xu bh. Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):196-9. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16875604 Chinese.

8

[Docetaxel combined with cisplatin in the treatment of anthracycline-resistant advanced breast cancer].

Xu BH, Zhao LM, Wang JY, Yuan P. Xu BH, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jun;28(6):471-3. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17152499 Chinese.

9

[Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].

Guan Y, Xu BH, Li Q, Zhang P, Zhao LM, Yuan P, Wang JY. Guan Y, et al. Among authors: xu bh. Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):77-81. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18353207 Chinese.

10

Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis.

Yu D, Zhang X, Liu J, Yuan P, Tan W, Guo Y, Sun T, Zhao D, Yang M, Liu J, Xu B, Lin D. Yu D, et al. Clin Cancer Res. 2008 May 1;14(9):2878-86. doi: 10.1158/1078-0432.CCR-07-1612. Clin Cancer Res. 2008. PMID: 18451256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

575 results

Search Page

Filters